Use este identificador para citar ou linkar para este item:
http://hdl.handle.net/1843/42086| Tipo: | Artigo de Periódico |
| Título: | Liposomes containing gadodiamide: preparation, physicochemical characterization, and in vitro cytotoxic evaluation |
| Autor(es): | Ana Luiza Chaves Maia Christian Fernandes Cynthia Nara Pereira de Oliveira Claudia Salviano Teixeira Mariana Silva Oliveira Daniel Crístian Ferreira Soares Gilson Andrade Ramaldes |
| Resumo: | Background: The aim of this study was to develop, characterize and assess the cytotoxic activity of pHsensitive (pHL-Gd), stealth pH-sensitive (SpHL-Gd), and conventional (convL-Gd) liposomes containing gadodiamide (Gd-DTPA-BMA). Methods: Formulations were prepared by reverse-phase evaporation method and their physicochemical properties were evaluated by means of particle size, zeta potential, and Gd-DTPA-BMA entrapment. SpHL-Gd was considered being the most promising liposome, since it combines stealth and fusogenic characteristics that might contribute to achieve higher therapeutic efficiency. Their drug encapsulation percentages have been optimized satisfactorily. The addition of Gd-DTPA-BMA at 125 μmol/mL in the SpHL-Gd preparation allowed obtaining liposomes with appropriate encapsulation percentage (20.3 ± 0.1%) and entrapment (25.4 ± 0.1 μmol/mL). Results: The cytotoxic studies on the 4T1 breast cancer cell line demonstrated that liposomes-loaded with Gd-DTPA-BMA inhibited cancer cell. pHL-Gd and SpHL-Gd liposomes showed higher activity than convL-Gd and free Gd-DTPA-BMA, indicating that the pH-sensitive characteristic was important to improve intracellular delivery. Conclusion: The presence of polyethylene glycol (PEG) in the SpHL-Gd formulation did not affect the pH-sensitivity and internalization. Therefore, the results of this study suggest the feasibility of liposomes containing Gd-DTPA-BMA as a new promising controlled delivery system. |
| Assunto: | Atividade citotóxica Lipossomas Gadodiamida Caracterização físico-química |
| Idioma: | eng |
| País: | Brasil |
| Editor: | Universidade Federal de Minas Gerais |
| Sigla da Instituição: | UFMG |
| Departamento: | FAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS |
| Tipo de Acesso: | Acesso Restrito |
| Identificador DOI: | 10.2174/1567201813666160907095404 |
| URI: | http://hdl.handle.net/1843/42086 |
| Data do documento: | 2017 |
| metadata.dc.url.externa: | https://www.eurekaselect.com/article/78251 |
| metadata.dc.relation.ispartof: | Current Drug Delivery |
| Aparece nas coleções: | Artigo de Periódico |
Arquivos associados a este item:
Não existem arquivos associados a este item.
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.